Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYouGov Regulatory News (YOU)

Share Price Information for YouGov (YOU)

Share Price is delayed by 15 minutes
Get Live Data
214.80    7.40 (3.57%)
Bid:
213.60
Ask:
216.00
Spread: 2.40 (1.124%)
Market Cap: £251.65m
YOU Live PriceLast checked at - London Stock Exchange

Intraday YouGov Share Chart

Share Awards and Block Listing Application

16 Nov 2021 16:04

RNS Number : 5820S
YouGov PLC
16 November 2021
 

 

16 November 2021

 

YouGov plc

 

("YouGov" or "the Group" or "the Company") 

 

Share Awards and Block Listing Application

 

YouGov, the international research and data analytics group, announces that on 16 November 2021 the awards granted in 2019 under the Group's Deferred Share Bonus Plan established in 2014 ("DSBP 2014"), relating to 87,980 shares, vested. The holders of the awards may exercise their rights to acquire YouGov shares at any time up to 16 November 2026. This is the final vesting of awards granted under this share plan.

 

Application has been made to the London Stock Exchange for admission to AIM of 87,980 ordinary shares of 0.2p each to be added to the Company's existing Block Listing in respect of the DSBP 2014. Shares admitted under this Block Listing will rank pari passu with existing ordinary shares. It is anticipated that admission under the Block Listing will take place on 19 November 2021.

 

 

Enquiries

 

YouGov plc 

Tilly Heald / Hannah Jethwani

 

020 7012 6000 

 

FTI Consulting 

Charles Palmer / Elena Kalinskaya 

 

020 3727 1000 

 

Numis Securities (NOMAD and Joint Broker) 

Nick Westlake / Hugo Rubinstein / Matt Lewis 

 

 

020 7260 1000 

 

Berenberg (Joint Broker) 

Mark Whitmore / Alix Mecklenburg-Solodkoff  

 

 

020 3207 7800 

 

 

 

 

About YouGov 

 

YouGov is an international research and data analytics group. 

 

Our mission is to supply a continuous stream of accurate data into what the world thinks, so that organisations can better serve the communities that sustain them.

 

Our 17 million registered members provide us with a highly engaged proprietary panel that delivers thousands of data points on consumer opinions, attitudes and behaviour on a daily basis. We combine this continuous stream of data with our research expertise to provide insights that enable intelligent decision-making and informed conversations. 

 

With operations in the UK, the Americas, Europe, the Middle East, India and Asia Pacific, YouGov has one of the world's largest research networks. 

 

YouGov 

Best panel Best data Best tools 

 

For further information visit yougov.com. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKABKABDDNDD
Date   Source Headline
5th Feb 20245:14 pmRNSDirector/PDMR and PCA Dealing Replacement
5th Feb 20244:39 pmRNSDirector/PDMR and PCA Dealing
2nd Feb 20247:00 amRNSHalf-year Trading Update and Notice of Results
1st Feb 20242:53 pmRNSTotal Voting Rights
18th Jan 20241:31 pmRNSDirector/PDMR Dealing
9th Jan 20247:00 amRNSYouGov completes the acquisition of GfK’s CPS
8th Jan 20247:00 amRNSYouGov acquires KnowledgeHound
29th Dec 20237:00 amRNSHolding(s) in Company
15th Dec 20235:33 pmRNSDirector/PDMR Dealings
15th Dec 20235:13 pmRNSGrant of awards under LTIP 2023
14th Dec 20235:33 pmRNSDirector/PDMR Dealings
7th Dec 20232:29 pmRNSResult of AGM
1st Dec 20231:26 pmRNSTotal Voting Rights and Block Listing Return
27th Nov 202312:21 pmRNSHolding(s) in Company
8th Nov 202312:28 pmRNSDirector/PDMR Shareholding
7th Nov 20239:08 amRNSAnnual Report and Notice of AGM Replacement
7th Nov 20237:00 amRNSAnnual Report, Notice of AGM and Auditor Change
1st Nov 202312:52 pmRNSTotal Voting Rights
16th Oct 20232:16 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSFull Year Results for the year ended 31 July 2023
2nd Oct 20237:00 amRNSNew EUR280 million term loan facility signed
1st Sep 202310:22 amRNSTotal Voting Rights
1st Aug 20233:48 pmRNSTotal Voting Rights
28th Jul 20237:01 amRNSUpdate to the Board of Directors
28th Jul 20237:00 amRNSPre-Close Trading Update and Notice of Results
7th Jul 20237:00 amRNSResults of Placing
6th Jul 20235:22 pmRNSProposed Placing of New Ordinary Shares
6th Jul 20235:21 pmRNSYouGov to acquire GfK’s Consumer Panel Business
6th Jul 20231:43 pmRNSStatement regarding media speculation
3rd Jul 20235:04 pmRNSTotal Voting Rights
6th Jun 20234:20 pmRNSDirector/PDMR Dealing
1st Jun 20233:50 pmRNSTotal Voting Rights and Block Listing Return
19th May 20234:58 pmRNSDirector/PDMR Dealing
17th May 20237:00 amRNSCapital Markets Day Event
26th Apr 20234:08 pmRNSIssue of Ordinary Shares & Total Voting Rights
14th Apr 20237:00 amRNSAppointment of Steve Hatch as CEO
12th Apr 20237:00 amRNSHolding(s) in Company
5th Apr 20235:14 pmRNSHolding(s) in Company
5th Apr 20235:13 pmRNSHolding(s) in Company
5th Apr 20235:12 pmRNSHolding(s) in Company
5th Apr 20237:00 amRNSNotice of Capital Markets Day
3rd Apr 20235:52 pmRNSPDMR / PCA Dealings
3rd Apr 20232:37 pmRNSTotal Voting Rights
21st Mar 20237:00 amRNSResults for the six months to 31 January 2023
1st Mar 20238:00 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSAppointment of Non-Executive Directors
27th Jan 20237:00 amRNSPre-Close Trading Update and Notice of Results
26th Jan 202312:21 pmRNSHolding(s) in Company
10th Jan 20232:30 pmRNSHolding(s) in Company
3rd Jan 20232:03 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.